APA način citiranja

Haas, B., Eckstein, N., Pfeifer, V., Mayer, P., & Hass, M. D. S. (2014). Efficacy, safety and regulatory status of SGLT2 inhibitors: Focus on canagliflozin. Nutr Diabetes.

Čikaški stil citiranja

Haas, B., N. Eckstein, V. Pfeifer, P. Mayer, i M D S. Hass. "Efficacy, Safety and Regulatory Status of SGLT2 Inhibitors: Focus On Canagliflozin." Nutr Diabetes 2014.

MLA način citiranja

Haas, B., et al. "Efficacy, Safety and Regulatory Status of SGLT2 Inhibitors: Focus On Canagliflozin." Nutr Diabetes 2014.